Home › Bladder Cancer › District of Columbia › Washington
Bladder Cancer clinical trials in Washington, DC
26 studies for Bladder Cancer are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
- Walter Reed National Military Medical Center, Bethesda · 7 mi away
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RecruitingPhase 3
- Sibley Memorial Hospital, Washington D.C.
Evaluation for NCI Surgery Branch Clinical Research Protocols
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi away
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecruitingPhase 1/2
- Sibley Memorial Hospital Pharmacy Department, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
RecruitingPhase 3
- Sibley Memorial Hospital ( Site 0849), Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- MedStar Washington Hospital Center, Washington D.C.
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- National Institutes of Health, Bethesda · 7 mi away
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecruitingPhase 1/2
- The George Washington Medical Faculty Associates, Washington D.C.
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
RecruitingPhase 2/3
- Sibley Memorial Hospital, Washington D.C.
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecruitingPhase 2
- Medstar Washington Hospital Center, Washington D.C.
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
RecruitingPhase 2
- Johns Hopkins University: Sibley Memorial Hospital, Washington D.C.
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RecruitingObservational studyHealthy volunteers welcome
- Cancer Support Community Research & Training Institute, Washington D.C.
Renal Retention in High Grade Upper Tract Urothelial Cancer
RecruitingPhase 2
- Johns Hopkins University: Sibley Memorial Hospital, Washington D.C.
Blue Light Cystoscopy With Cysview® Registry
RecruitingObservational study
- Sibley Memorial Hospital, Washington D.C.
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
Recruiting
- Sibley Memorial Hospital, Washington D.C.
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
RecruitingPhase 3
- Sibley Memorial Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi away
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi away
Gender Related Coping and Survivorship for Genitourinary Cancers
RecruitingObservational study
- Sibley Memorial Hospital, Washington D.C.
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY35 studies
- Houston, TX31 studies
- Nashville, TN31 studies
- Dallas, TX27 studies
- Boston, MA26 studies
- Baltimore, MD24 studies
- Los Angeles, CA24 studies
- St. Louis, MO22 studies
- Seattle, WA21 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- Edison, NJ21 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
- Lymphoma23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.